• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2000年至2008年期间,意大利莱尼亚诺综合医院艾滋病患者的特征及其对抗逆转录病毒疗法的反应。

Characterisation of AIDS presenters and their response to antiretroviral therapy at legnano general hospital (Italy) during the period 2000-2008.

作者信息

Mena Maurizio, Magnani Carlo, Villa Massimo, Re Tiziana, Perini Paolo, De Paschale Massimo, Cagnin Debora, Cerulli Teresa, Clerici Pierangelo, Viganò Paolo

机构信息

Department of Infectious Diseases, Ospedale Civile of Legnano, Legnano, Milan, Italy.

出版信息

New Microbiol. 2010 Jul;33(3):207-14.

PMID:20954438
Abstract

The aim of this study was to characterise the AIDS presenters diagnosed between 2000 and 2008 in Legnano (Italy), and describe their initial response to highly active antiretroviral therapy (HAART) and trends over time. Seventy-six (48.7%) of 156 patients diagnosed as having AIDS in the period 2000-2008 were AIDS presenters. The proportion of AIDS presenters increased from 23.8% in 2000 to 70.6% in 2008 (p = 0.009). The major risk factors were heterosexual transmission and a foreign place of birth, and did not significantly change over time. The median CD4+ cell count at diagnosis was 30 cells/microl and the median level of HIV RNA was 5.38 log copies/ml, with no differences between the transmission risk groups. Fifteen AIDS presenters died of AIDS-defining diseases; the others started HAART (72% with 2 NRTIs + boosted PI), and 40% after a drug resistance test. The median duration of the initial HAART was 107 days. After three months, 34% of the patients had undetectable HIV-RNA levels and the median CD4+ cell count was 140 cells/microl; the corresponding figures after 12, 24 and 48 months were respectively 84%, 82.3% and 94.1%, and 310, 370 and 380 cells/microl. In conclusion, the AIDS presenters were mainly heterosexual men and immigrants. Their proportion increased significantly over time, and a substantial proportion maintained an immunovirological response to HAART.

摘要

本研究旨在对2000年至2008年期间在意大利莱尼亚诺被诊断出的艾滋病患者进行特征描述,并描述他们对高效抗逆转录病毒疗法(HAART)的初始反应及随时间的变化趋势。在2000 - 2008年期间被诊断为患有艾滋病的156名患者中,有76名(48.7%)是艾滋病患者。艾滋病患者的比例从2000年的23.8%增至2008年的70.6%(p = 0.009)。主要危险因素为异性传播和出生于国外,且随时间未发生显著变化。诊断时CD4 + 细胞计数的中位数为30个/微升,HIV RNA水平的中位数为5.38 log拷贝/毫升,不同传播风险组之间无差异。15名艾滋病患者死于艾滋病界定疾病;其他患者开始接受HAART(72%采用2种核苷类逆转录酶抑制剂 + 增强型蛋白酶抑制剂),40%在进行耐药性检测后开始治疗。初始HAART的中位疗程为107天。三个月后,34%的患者HIV - RNA水平检测不到,CD4 + 细胞计数的中位数为140个/微升;12个月、24个月和48个月后的相应数据分别为84%、82.3%和94.1%,以及310个/微升、370个/微升和380个/微升。总之,艾滋病患者主要是异性恋男性和移民。其比例随时间显著增加,且相当一部分患者对HAART保持免疫病毒学反应。

相似文献

1
Characterisation of AIDS presenters and their response to antiretroviral therapy at legnano general hospital (Italy) during the period 2000-2008.2000年至2008年期间,意大利莱尼亚诺综合医院艾滋病患者的特征及其对抗逆转录病毒疗法的反应。
New Microbiol. 2010 Jul;33(3):207-14.
2
Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.103例接受12个月高效抗逆转录病毒治疗的晚期艾滋病患者的临床结局和免疫重建
Chin Med J (Engl). 2006 Oct 20;119(20):1677-82.
3
Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.在高效抗逆转录病毒治疗时代,香港一组晚期1型艾滋病毒病患者的死亡和艾滋病进展延迟情况。
Clin Infect Dis. 2004 Sep 15;39(6):853-60. doi: 10.1086/423183. Epub 2004 Aug 27.
4
Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.维持高效抗逆转录病毒疗法对晚期HIV感染且治疗反应不佳患者艾滋病相关事件的影响。
Clin Infect Dis. 2006 Mar 15;42(6):878-84. doi: 10.1086/500210. Epub 2006 Feb 8.
5
Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.预测HIV感染患者在一线高效抗逆转录病毒治疗期间短期CD4+ T细胞恢复的程度。
Antivir Ther. 2010;15(2):165-75. doi: 10.3851/IMP1513.
6
Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.基线 CD4(+)T 细胞计数对中国 HIV/AIDS 患者应用奈韦拉平为基础的高效抗逆转录病毒治疗疗效的影响:一项前瞻性、多中心研究。
Chin Med J (Engl). 2009 Oct 20;122(20):2497-502.
7
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.高效抗逆转录病毒疗法(HAART)对HIV的抑制作用可保留晚期免疫重建艾滋病患者的认知功能。
AIDS. 2007 May 31;21(9):1109-17. doi: 10.1097/QAD.0b013e3280ef6acd.
8
Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.高效抗逆转录病毒疗法对伊洛林大学教学医院收治的艾滋病患者CD4细胞计数和体重的影响。
Niger J Clin Pract. 2008 Dec;11(4):312-5.
9
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.联合抗逆转录病毒治疗中断与临床疾病进展至艾滋病或死亡的风险。
HIV Med. 2007 Mar;8(2):96-104. doi: 10.1111/j.1468-1293.2007.00436.x.
10
CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.在接受高效抗逆转录病毒治疗并实现持续病毒学抑制的患者中,治疗开始6年后的CD4 +细胞计数。
Clin Infect Dis. 2007 Feb 1;44(3):441-6. doi: 10.1086/510746. Epub 2006 Dec 20.